Can a smart sensor stop prediabetes in its tracks?

NCT ID NCT07639593

Not yet recruiting Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will give 100 adults with prediabetes a continuous glucose monitor (CGM) called Stelo, which tracks blood sugar every few minutes. The goal is to see if seeing real-time sugar levels helps people make better food and activity choices, lowering their A1c and improving health. The trial is not yet recruiting and will run at two clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Stelo CGM (continuous glucose monitor device)
What this could lead to: If successful, this could show that using a CGM helps people with prediabetes better manage their blood sugar and adopt healthier habits, potentially preventing progression to type 2 diabetes.
What could go wrong: This is a small, early-stage trial with only 100 participants and no control group, so results may not apply broadly. The device itself is not a treatment—it only provides information, and behavior change is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREDIABETES

Contacts and locations

Locations

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.